Category Archives: Pharma & Biotech

Pharma & Biotech Press Releases & News distributed via EuropaWire

The leading provider of molecular Sample to Insight solutions QIAGEN announces a major expansion of its digital PCR (dPCR) assay offerings

13 new kits and assays allow for quantification of AAV viral titer and residual host cell DNA in cell and gene therapy Custom assay design provides dPCR users with access to tailored multiplex assays for use beyond biopharma applications Milestone … Read the full press release

Le principal fournisseur de solutions moléculaires Sample to Insight QIAGEN annonce une expansion majeure de ses offres de tests PCR numériques (dPCR)

13 nouveaux kits et tests permettent de quantifier le titre viral d’AAV et l’ADN résiduel de la cellule hôte en thérapie cellulaire et génique La conception de tests personnalisés permet aux utilisateurs de dPCR d’accéder à des tests multiplex personnalisés … Read the full press release

QIAGEN, der führende Anbieter von molekularen Sample-to-Insight-Lösungen, kündigt eine bedeutende Erweiterung seines Angebots an digitalen PCR (dPCR)-Assays an

13 neue Kits und Tests ermöglichen die Quantifizierung von AAV-Titern und restlicher Wirtszell-DNA in der Zell- und Gentherapie Custom Assay Design Service bietet Nutzern von dPCR Zugang zu maßgeschneiderten Multiplex-Assays über den Einsatz in Biopharma-Anwendungen hinaus Meilenstein mit mehr als … Read the full press release

Metadeq Announces Breakthrough Non-Invasive Blood Test that Solves NASH Diagnosis Problem

New test featured today in Gut, a leading international journal published by BMJ, uses A.I. to accurately predict the stages of the whole spectrum of liver diseases, from NAFLD to NASH and liver fibrosis (PRESS RELEASE) BOSTON, MA, United States, … Read the full press release

SGS to strengthen its leading global position on the cosmetics and personal care testing market with the acquisition of proderm GMBH in Germany

(PRESS RELEASE) GENEVA, 8-Jul-2022 — /EuropaWire/ — SGS, the world’s leading testing, inspection and certification company, has announced the company will strengthen its leading global position in the cosmetics and personal care testing market with the acquisition of proderm GMBH … Read the full press release

SGS renforce sa position de leader mondial sur le marché des tests de cosmétiques et de soins personnels avec l’acquisition de proderm GMBH en Allemagne

(COMMUNIQUÉ DE PRESSE) GENEVA, 8-Jul-2022 — /EuropaWire/ — SGS, le leader mondial des tests, de l’inspection et de la certification, a annoncé que la société renforcera sa position de leader mondial sur le marché des tests cosmétiques et de soins … Read the full press release

An innovative non-invasive imaging technique unveiled by University of East Anglia researchers can create detailed 4D flow images of the heart

(PRESS RELEASE) NORWICH, 27-Jun-2022 — /EuropaWire/ — University of East Anglia, a public research university based in Norwich, England, has announced an innovative non-invasive imaging technique developed by its researchers that can create detailed 4D flow images of the heart. … Read the full press release

Eine innovative nicht-invasive Bildgebungstechnik, die von Forschern der University of East Anglia vorgestellt wurde, kann detaillierte 4D-Flussbilder des Herzens erstellen

(PRESSEMITTEILUNG) NORWICH, 27-Jun-2022 — /EuropaWire/ — Die University of East Anglia, eine öffentliche Forschungsuniversität mit Sitz in Norwich, England, hat eine von ihr entwickelte innovative nicht-invasive Bildgebungstechnik angekündigt Forscher, die detaillierte 4D-Flussbilder des Herzens erstellen können. Die hochmoderne Bildgebungstechnologie kann … Read the full press release

Bosch Healthcare Solutions and BioGX unveil new real-time PCR rapid test capable of detecting 4 pathogens of sexually transmitted infections (STIs)

New real-time PCR rapid test for detection of four STI First Vivalytic test in cooperation with development partner BioGX Positive test results available within an hour directly at the point of care (PRESS RELEASE) WAIBLINGEN, Germany, 9-Jun-2022 — /EuropaWire/ — … Read the full press release

Bosch Healthcare Solutions et BioGX dévoilent un nouveau test rapide PCR en temps réel capable de détecter 4 agents pathogènes des infections sexuellement transmissibles (IST)

Nouveau test rapide PCR en temps réel pour la détection de quatre IST Premier test Vivalytic en coopération avec le partenaire de développement BioGX Résultats de test positifs disponibles dans l’heure directement au point de service (COMMUNIQUÉ DE PRESSE) WAIBLINGEN, … Read the full press release

Diabeloop, a key player in therapeutic AI applied to insulin delivery, announces 70 million euros new financing round to accelerate its international expansion

High-growth diabetes company Diabeloop closes its Series C financing round – led by LBO France, joined by Terumo Corporation, Innovacom and backed by Diabeloop’s historical partners – to power the company’s commercial roll-out and global expansion. (PRESS RELEASE) PARIS, 2-Jun-2022 … Read the full press release

Roche extends until 2028 its commitment to the WFH Humanitarian Aid Program aimed at helping people with haemophilia

The renewed commitment will provide continued preventative (prophylactic) treatment to as many as 1,000 people with haemophilia A in locations where there is little to no access to haemophilia treatment Prophylactic treatment aims to prevent bleeds and allow people with haemophilia to achieve quality of life … Read the full press release

Diabeloop presents new real-life results of DBLG1® System: Confirmed improvement in Time In Range +18.4 percentage points; Reduction of time spent in hypoglycemia to only 0.9%

(PRESS RELEASE) PARIS, 28-Apr-2022 — /EuropaWire/ — ATTD 2022 – Diabeloop, pioneer in therapeutic artificial intelligence for diabetes management, presents today new results from a real-life cohort in Germany. The data show a constant improvement in Time In Range (70-180 … Read the full press release

GlaxoSmithKline: US FDA regulatory submission acceptance of New Drug Application for daprodustat, an oral hypoxia-inducible factor prolyl hydroxylase inhibitor

(PRESS RELEASE) LONDON, 19-Apr-2022 — /EuropaWire/ — GlaxoSmithKline plc (LON: GSK), a British multinational science-led healthcare company, has announced the third major regulatory milestone for its daprodustat, an oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI), for the potential treatment of … Read the full press release

GlaxoSmithKline : acceptation de la soumission réglementaire de la FDA américaine pour la demande de nouveau médicament pour le daprodustat, un inhibiteur oral de la prolyl hydroxylase du facteur inductible par l’hypoxie

(COMMUNIQUÉ DE PRESSE) LONDRES, 19-Apr-2022 — /EuropaWire/ — GlaxoSmithKline plc (LON : GSK), une multinationale scientifique britannique , a annoncé la troisième étape réglementaire majeure pour son daprodustat, un inhibiteur oral du facteur prolyl hydroxylase inductible par l’hypoxie (HIF-PHI), pour le … Read the full press release

University of Bristol joins a new UK genetics network aimed at better linking mouse genetics research to clinical advances

(PRESS RELEASE) BRISTOL, 19-Apr-2022 — /EuropaWire/ — University of Bristol, a red brick research university, has announced that it is joining UK’s new National Mouse Genetics Network, a distributed challenge-led research clusters working with the Mary Lyon Centre to accelerate … Read the full press release

L’Università di Bristol si unisce a una nuova rete genetica britannica volta a collegare meglio la ricerca genetica sui topi ai progressi clinici

(COMMUNIQUÉ DE PRESSE) BRISTOL, 19-Apr-2022 — /EuropaWire/ — University of Bristol, a red brick research university, has announced that it is joining UK’s new National Mouse Genetics Network, a distributed challenge-led research clusters working with the Mary Lyon Centre to … Read the full press release

Diabeloop adapts its self-learning, personalized insulin automatization software to be used with insulin pens

(PRESS RELEASE) PARIS, 12-Apr-2022 — /EuropaWire/ — Diabeloop, a pioneer in the field of therapeutic artificial intelligence, leverages the potential of its diabetes technology to enable the integration of insulin pens into its hybrid closed-loop system using a unique app. … Read the full press release

WACKER and CordenPharma joint bid to become part of Germany’s Pandemic Preparedness Plan has been accepted

(PRESS RELEASE) MUNICH/ HALLE, PLANKSTADT, 11-Apr-2022 — /EuropaWire/ — WACKER Group (ETR: WCH), a German multinational chemical company, and CordenPharma, the global pharmaceutical service & manufacturing platform of International Chemical Investors Group (ICIG), have announced that their joint bid to … Read the full press release

L’offre conjointe de WACKER et CordenPharma pour faire partie du plan allemand de préparation à la pandémie a été acceptée

(COMMUNIQUÉ DE PRESSE) MUNICH/ HALLE, PLANKSTADT, 11-Apr-2022 — /EuropaWire/ — WACKER Group (ETR : WCH), une multinationale chimique allemande, et CordenPharma , le service pharmaceutique mondial & plate-forme de fabrication de l’International Chemical Investors Group (ICIG), ont annoncé que leur offre … Read the full press release

On World Bipolar Day ALCEDIAG announces EIT Health supported EDIT-B Consortium validating innovative blood diagnostic test for bipolar disorder

(PRESS RELEASE) PARIS AND MONTPELLIER, 30-Mar-2022 — /EuropaWire/ — ALCEDIAG announces the launch of the EDIT-B Consortium, supported by the European Institute of Innovation and Technology for Health (EIT Health). This newly formed European public-private partnership aims at advancing precision … Read the full press release

Sanofi und IGM Biosciences kooperieren bei einer neuen Klasse von Antikörper-Medikamenten zur Behandlung von Krebs, Immunologie und entzündlichen Erkrankungen

(PRESSEMITTEILUNG) SANOFI, 29-Mar-2022 — /EuropaWire/ — Sanofi (EPA: SAN), ein globales biopharmazeutisches Unternehmen, das sich auf die menschliche Gesundheit konzentriert , hat eine exklusive weltweite Kooperationsvereinbarung mit IGM Biosciences, Inc. (Nasdaq: IGMS), einem Biotechnologieunternehmen im klinischen Stadium, das sich auf … Read the full press release

Sanofi and IGM Biosciences and partner over new class of antibody medicines for the treatment of cancer, immunology, and inflammatory diseases

(PRESS RELEASE) SANOFI, 29-Mar-2022 — /EuropaWire/ — Sanofi (EPA: SAN), a global biopharmaceutical company focused on human health, has announced an exclusive worldwide collaboration agreement signed with IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company focused on creating and … Read the full press release

Sanofi gibt auf seinem Immunology Investor Event ein Update zu seiner Immunologie-Strategie bekannt

(PRESSEMITTEILUNG) PARIS, 29-Mar-2022 — /EuropaWire/ — Sanofi (EPA: SAN), ein globales biopharmazeutisches Unternehmen, das sich auf die menschliche Gesundheit konzentriert , hat angekündigt, dass das Unternehmen auf seinem Immunology Investor Event, das am Dienstag, den 29. März ab 14:00 Uhr … Read the full press release

Sanofi to provide an update on its Immunology strategy at its Immunology Investor Event

(PRESS RELEASE) PARIS, 29-Mar-2022 — /EuropaWire/ — Sanofi (EPA: SAN), a global biopharmaceutical company focused on human health, has announced that the company will provide an update on its Immunology strategy at its Immunology Investor Event, which is taking place … Read the full press release

Global & Europe Mental Health Software and Devices Market to Witness a Revenue of USD 13367.12 Million by 2030 by Growing with a CAGR of 13.28% During 2021-2030; Increasing Concern for Mental Health Disorders to Drive Market Growth

Europe Mental Health Software and Devices Market to Experience Great Bounce in European Markets (PRESS RELEASE) NEW YORK, 21-Mar-2022 — /EuropaWire/ — Every year, over 7 Million people are known to die by suicide, one of the major concerns of … Read the full press release

AstraZeneca lanza un desafío posdoctoral de I+D global en EXPO 2020 Dubái

El desafío tiene como objetivo ayudar al descubrimiento de avances transformadores en las áreas de enfermedades centrales de AstraZeneca. Las propuestas exitosas asegurarán puestos de investigación posdoctorales totalmente financiados (COMUNICADO DE PRENSA) CAMBRIDGE, 17-Mar-2022 — /EuropaWire/ — AstraZeneca (LSE/STO/Nasdaq: AZN), … Read the full press release

AstraZeneca launches a global R&D Postdoctoral Challenge at EXPO 2020 Dubai

The challenge aims at helping the discovery of transformative breakthroughs across AstraZeneca’s core disease areas Successful proposals will secure fully funded postdoctoral research positions (PRESS RELEASE) CAMBRIDGE, 17-Mar-2022 — /EuropaWire/ — AstraZeneca (LSE/STO/Nasdaq: AZN), a British-Swedish multinational pharmaceutical and biotechnology … Read the full press release

La división Sandoz de Novartis amplía su cartera de medicamentos respiratorios con la adquisición de la empresa británica Coalesce Product Development Limited

Sandoz obtiene capacidades y activos significativos en el desarrollo de dispositivos médicos y medicamentos que apuntan a importantes oportunidades de crecimiento en genéricos complejos y respiratorios Las enfermedades respiratorias son la principal causa de muerte y discapacidad e imponen una … Read the full press release

Novartis division Sandoz expands respiratory medicines portfolio with the acquisition of British company Coalesce Product Development Limited

Sandoz gains significant capabilities and assets in medical and drug device development that target major growth opportunities in respiratory and complex generics Respiratory diseases are leading cause of death and disability and impose huge financial burden on patients worldwide Acquisition … Read the full press release